Measuring Lifestyle Medicine in Vietnamese Healthcare: What Outcomes and Quality Indicators Should We Track?

Measuring Lifestyle Medicine in Vietnamese Healthcare: What Outcomes and Quality Indicators Should We Track?

Last reviewed: 21 September 2026

Lifestyle Medicine becomes much more meaningful when it moves from advice to measurable care.

A patient may say that they are eating better, exercising more or sleeping better. A clinician may feel that a program is working. A hospital may report that hundreds of people have attended a Lifestyle Medicine consultation or education session. These observations can be useful, but they do not by themselves tell us whether care has improved.

For a healthcare organization, the more important questions are: Are we delivering the care we intended to deliver? Are patients benefiting? Are there unintended harms? Are people able to stay engaged? Is the model reaching the population it was designed to serve? And can the organization sustain it over time?

These questions are increasingly relevant in Viet Nam. The country is strengthening prevention and community-based management of noncommunicable diseases. In September 2026, the World Health Organization highlighted the expansion of noncommunicable disease services through grassroots healthcare, with services reaching around 10 million people in Viet Nam.[2] Viet Nam's Law on Disease Prevention No. 114/2025/QH15, effective from 1 July 2026, also provides a stronger legal context for prevention, early detection, follow-up and management of noncommunicable diseases.[3]

If Lifestyle Medicine is to contribute meaningfully to this environment, measurement should be part of implementation from the beginning rather than added after a program has already been launched.

Lifestyle Medicine should be measured like healthcare

The international Lifestyle Medicine competency framework already points in this direction. The 2025 Lifestyle Medicine Core Competencies include creating and using data from office systems such as electronic health records in clinical decision-making and care, including tracking screening frequency, test results, referrals and recommended follow-up. They also include collaborative and chronic care models, quality improvement using approaches such as Plan-Do-Study-Act cycles, and methods for assessing intervention effectiveness, with patient activation measures and therapeutic alliance measures given as examples.[1]

This matters because Lifestyle Medicine should not be evaluated only by whether an activity was delivered. A nutrition consultation, physical activity recommendation or behavior-change session can be completed without producing a meaningful improvement in health.

At the same time, measurement needs to be proportionate. A hospital does not need to collect dozens of variables simply because they are available. Collecting too much information can increase workload, reduce data quality and distract from the clinical purpose of the program. The objective should be to collect enough information to understand whether the model is working, for whom it is working, whether it is safe and what needs to improve.

Measurement for improvement is not the same as research

This distinction is particularly important for healthcare organizations beginning a Lifestyle Medicine pilot. Research generally seeks to generate new knowledge that may be applicable beyond the setting in which it is produced. Quality improvement has a different primary purpose: learning whether a change introduced into a particular healthcare system is producing the intended improvement.

The Institute for Healthcare Improvement distinguishes measurement for research from measurement for learning and improvement and recommends gathering “just enough” data to support sequential learning rather than collecting large amounts of information simply in case they become useful. It commonly organizes quality-improvement measures into outcome, process and balancing measures and recommends following a small family of measures over time.[4]

For example, a hospital introducing a hypertension pathway does not necessarily need a randomized trial to determine whether its new workflow is functioning. It does need to know whether eligible patients are being assessed, whether appropriate interventions and referrals occur, whether follow-up happens, whether blood pressure outcomes improve and whether the changes create new safety or operational problems.

The distinction between research and quality improvement does not by itself determine whether formal ethics review or another institutional review process is required. The purpose, design, intended use of the results and applicable organizational, ethical and regulatory requirements should still be considered. Improvement work should be rigorous, but routine measurement should not become so complicated that clinical teams cannot sustain it.

There should not be one universal “Lifestyle Medicine score”

Lifestyle Medicine addresses multiple behaviors and multiple clinical conditions. A single score combining nutrition, physical activity, sleep, stress, social connection and substance use may look attractive because it appears simple, but it can also hide clinically important differences.

One patient may be physically active but have uncontrolled hypertension. Another may make substantial dietary changes while continuing to smoke. A third may improve several lifestyle behaviors but develop symptomatic hypotension as weight, diet and medication requirements change. Compressing these different situations into one composite number can make results easier to display while making them less useful clinically.

For most healthcare organizations, measurement should instead begin with the clinical purpose and target population. A hypertension pathway should primarily measure outcomes relevant to hypertension. A tobacco-treatment pathway should measure tobacco-use outcomes. An obesity service should examine more than body weight alone. A perioperative program should measure outcomes related to preparation for surgery and recovery. Lifestyle behaviors can then be measured alongside these clinical outcomes to help explain whether the intervention is changing the factors it was designed to change.

A proposed VLMA framework for measuring Lifestyle Medicine implementation

The following framework is proposed by the Vietnam Lifestyle Medicine Alliance as a practical structure for pilot programs and healthcare implementation in Viet Nam. It is not a national quality standard, accreditation requirement or regulatory indicator set.

A useful measurement system can consider seven connected domains: clinical outcomes, behavioral outcomes, patient-reported outcomes, care-process measures, safety and balancing measures, equity, and implementation and sustainability. Not every program needs every possible indicator within each domain. The purpose is to avoid judging success from only one perspective.

1. Clinical outcomes: Did health improve?

Clinical outcomes should reflect the condition and population being treated. For a hypertension pathway, relevant measures might include mean blood pressure, change from baseline or the proportion of eligible patients reaching an evidence-based treatment target appropriate to the population and clinical guideline being used. For diabetes care, glycemic measures may be relevant. Cardiometabolic programs may also consider lipid parameters and other clinically appropriate risk indicators.

An obesity pathway should generally avoid treating body weight as the only meaningful outcome. Depending on the program, relevant outcomes may include weight or waist-related measures alongside blood pressure, glycemic status, metabolic health, physical function, symptoms and quality of life.

Tobacco treatment should measure meaningful tobacco-use outcomes rather than simply counting how many people were advised to stop smoking. The World Health Organization recommends that brief cessation advice be routinely offered to tobacco users in healthcare settings, while people interested in quitting should have access to more intensive behavioral support and, where clinically appropriate, pharmacological treatment.[5]

Similarly, a physical-activity program should not be judged only by the number of exercise recommendations issued. Depending on the clinical purpose, actual activity levels, functional capacity, symptoms or disease-specific outcomes may be relevant. International recommendations can provide useful reference points, but individual clinical targets still need to reflect age, functional ability, disability, health status and other relevant circumstances.

The central principle is that the core clinical outcome measures should be directly connected to the reason the program exists.

2. Behavioral outcomes: Did the targeted behavior actually change?

Clinical outcomes may take time to change. Behavioral measures can help organizations understand whether the intervention is influencing the pathway through which improvement is expected. Depending on the program, these measures might include physical activity, sedentary time, tobacco status, dietary behaviors, sleep duration or quality, alcohol-related behaviors, adherence to agreed action plans or participation in meaningful social activities.

These measures should be selected carefully. A program should not measure all six Lifestyle Medicine pillars simply because they exist. If the intervention is focused primarily on tobacco cessation, tobacco-related measures should be central. If the purpose is cardiometabolic risk reduction, nutrition and physical activity may be more relevant.

Where validated instruments exist, organizations should consider whether they have been appropriately translated, culturally adapted and validated for the population being served. A questionnaire developed in another country should not automatically be assumed to measure the same construct accurately in Viet Nam.

Consistency is equally important. If physical activity is measured one way at baseline and another way at follow-up, apparent change may reflect the measurement method rather than the patient's behavior. Digital devices and wearables may help in selected programs, but greater technological precision does not automatically produce better clinical measurement. The information still needs a defined purpose and an interpretation that is meaningful for care.

3. Patient-reported outcomes: Did the patient experience meaningful benefit?

Laboratory values do not capture everything that matters to patients. A person may have improved blood pressure but feel that the treatment plan has become unrealistic or burdensome. Another may show only modest change in weight but meaningful improvement in physical function, symptoms, energy, confidence or quality of life.

Patient-reported outcomes can therefore add an important dimension to Lifestyle Medicine measurement. Depending on the pathway, organizations may assess quality of life, symptoms, patient-reported function, confidence in self-management, treatment burden or other outcomes that reflect the patient's experience.

The international Lifestyle Medicine competencies also identify patient activation measures and therapeutic alliance measures as examples of methods that can help assess intervention effectiveness.[1] These constructs can complement clinical and patient-reported outcomes, but they should not be treated as substitutes for them.

Quality of life may be assessed using appropriate validated instruments. The World Health Organization developed the WHO Quality of Life instruments for cross-cultural use and currently provides a Vietnamese WHOQOL-BREF translation resource. WHO also makes clear that the translations available through its website were not created by WHO and that WHO does not take responsibility for their content or accuracy. Organizations should therefore confirm the suitability, validation and administration of any instrument they intend to use in their population.[6]

The broader principle is that patients should help determine what successful care means.

4. Process measures: Did the care pathway actually happen?

Clinical outcomes tell us whether health changed. Process measures help explain whether the healthcare system delivered the intended care.

A Lifestyle Medicine pathway might measure the proportion of eligible patients receiving a standardized lifestyle assessment, the proportion with documented shared priorities, completion of indicated referrals, attendance at planned follow-up or whether relevant clinical measures are reassessed within the intended period.

These measures become especially useful when outcomes are disappointing. If blood pressure control does not improve, the reason may not be the intervention itself. Perhaps only half of eligible patients were assessed. Perhaps referrals were made but rarely completed. Perhaps follow-up occurred too late, or lifestyle assessments were documented in a way that other members of the team could not readily use.

Process measurement therefore turns a vague question such as “Why is this program not working?” into a more useful question: Where in the pathway is care breaking down?

Where feasible, these measures should be integrated into existing clinical records and quality systems rather than maintained in isolated spreadsheets. The Lifestyle Medicine Core Competencies specifically emphasize creating and using data from office systems, including electronic health records, to track screening, results, referrals and follow-up.[1]

5. Safety and balancing measures: Did improvement create a new problem?

Lifestyle interventions are often perceived as inherently low risk, but clinical implementation still requires safety monitoring. Changes in food intake, physical activity, body weight and other behaviors can alter clinical parameters. In people using glucose-lowering, antihypertensive or other relevant medicines, improvement may create a need for clinical review and treatment adjustment.

A program should therefore identify in advance which adverse events or safety signals matter. Depending on the pathway, these might include symptomatic hypotension, hypoglycemia, falls, injury, clinically concerning weight loss, worsening symptoms, unplanned escalation of care or other disease-specific complications.

Quality improvement also requires balancing measures, which examine whether an improvement in one part of the system is creating new problems elsewhere.[4] A program might improve follow-up rates while creating excessive clinician workload. More intensive digital monitoring might increase engagement for some patients while making access harder for people with limited digital literacy. A group program might reduce the resources required per participant but experience higher dropout among people who cannot attend at fixed times.

Measuring only benefits makes these consequences easy to miss.

6. Equity: Who is benefiting, and who is being left behind?

Average results can hide important differences. A Lifestyle Medicine program may show excellent overall improvement while most participants are younger, highly educated, digitally confident and able to attend appointments during working hours. The model may work well for those participants while failing to reach people with fewer resources or greater health needs.

The 2025 Lifestyle Medicine Core Competencies added a specific competency requiring Lifestyle Medicine interventions to be applied in the context of social determinants of health to improve outcomes and health equity.[1] The Institute for Healthcare Improvement similarly recommends disaggregating or stratifying data where appropriate to identify whether improvement efforts are closing, maintaining or widening equity gaps.

For implementation in Viet Nam, organizations can therefore consider whether participation, follow-up, attrition and outcomes differ across clinically or socially relevant groups. The appropriate categories will depend on the setting, the purpose of measurement and the lawful and ethical availability of the information. Age, sex, geographic access, financial barriers, occupation, disability or digital access may sometimes be relevant, but they should not be collected automatically.

Equity measurement should have a defined purpose and a plan for action. Collecting personal information simply because it might someday be useful creates burden and data-protection responsibilities without necessarily improving care.

7. Implementation and sustainability: Can the model work in the real healthcare system?

A Lifestyle Medicine intervention can produce good clinical results in a small pilot and still be difficult to implement at scale.

Implementation science distinguishes implementation outcomes from clinical and service outcomes. Proctor and colleagues proposed eight implementation outcomes: acceptability, adoption, appropriateness, feasibility, fidelity, implementation cost, penetration and sustainability.[7]

For a Vietnamese hospital or clinic, these concepts translate into practical questions. Do clinicians actually use the pathway? Do patients consider it acceptable? Does the intervention fit the clinical setting? Can it be delivered within available staffing and appointment structures? Are referrals available? Is the model delivered as intended? How far has it become integrated into routine care? What does implementation require in staff time and infrastructure? Can the organization continue the program after initial pilot funding or enthusiasm ends?

These measures may appear less visible than changes in blood pressure or weight, but they often determine whether an intervention becomes routine care or disappears after a pilot. Sustainability should therefore be measured rather than assumed.

A practical core measurement set for a pilot program

A pilot does not need a dashboard containing dozens of indicators. In many settings, a small set of well-defined measures will provide more useful information.

A practical pilot might include one or two core clinical outcome measures directly related to the target condition, one behavioral measure linked to the intervention, a patient-reported measure when relevant, several process measures covering assessment and follow-up, at least one safety or balancing measure, an equity analysis where appropriate, and one or more measures of feasibility or sustainability.

This is broadly consistent with the Institute for Healthcare Improvement's approach of using a small family of outcome, process and balancing measures rather than attempting to measure everything. The Institute notes that improvement initiatives typically use approximately four to ten measures across different parts of the system.[4]

The exact set should vary by pathway. A hypertension program and a tobacco-treatment program should not use identical dashboards simply because both are described as Lifestyle Medicine.

Every indicator needs an operational definition

Naming an indicator is not enough. “Blood pressure control,” for example, requires a defined population, measurement method, time period and clinical target. “Follow-up completed” requires a clear definition of what counts as follow-up and within what timeframe. “Improved physical activity” requires a consistent measurement method and a definition of meaningful change.

For every important indicator, the organization should define who is included, what is measured, the data source, the measurement interval, who is responsible for recording the information and how results will be interpreted. Where proportions are used, the numerator and denominator should be explicit.

Targets also require care. An international benchmark should not automatically become the performance target for a Vietnamese pilot. Targets should reflect applicable evidence-based clinical guidance, baseline performance, patient population, available resources and the purpose of the intervention.

Early quality-improvement work may therefore focus less on achieving an ambitious external benchmark and more on establishing a reliable process and demonstrating a meaningful direction of improvement over time.

Trend data are usually more useful than a single before-and-after number

A baseline measurement and a final result can tell part of the story, but they may miss important changes occurring during implementation. The Institute for Healthcare Improvement emphasizes plotting measures over time because patterns and trends can help teams understand whether changes are associated with improvement and whether improvement is sustained.[4]

A clinic might find that referral completion initially rises and then falls as patient volume increases. A hypertension program might improve quickly during the first few months and then plateau. A group program may maintain stable clinical outcomes while dropout gradually increases. Those patterns help teams understand where the system is changing and where additional adjustments are needed.

This approach is closely aligned with the Lifestyle Medicine competency requiring practitioners to design quality-improvement projects using tools such as Plan-Do-Study-Act cycles.[1] The purpose of measurement should therefore not be merely to produce an annual report. It should help teams decide what to change next.

Measurement should support clinical judgment, not replace it

Dashboards are useful only when numbers remain connected to clinical context. A reduction in body weight may represent therapeutic progress for one person and a clinical concern for another. Increased physical activity may be beneficial in one patient and inappropriate at a particular intensity in another. Lower blood pressure may indicate improved cardiometabolic health but may also require review if it is accompanied by symptoms or medication-related hypotension.

Lifestyle Medicine indicators should therefore support rather than replace professional assessment and shared decision-making. Clinical targets should follow the relevant evidence-based guidance for the condition being managed, and practitioners should remain within their authorized professional scope.

Good measurement should make clinical reasoning more visible rather than turning individualized care into a collection of automated targets.

Health data governance is part of quality measurement

Measurement creates data responsibilities because a Lifestyle Medicine program may collect clinical measurements, laboratory values, dietary information, physical activity, sleep information, mental health information, patient-reported outcomes and information generated through remote or wearable technologies.

Viet Nam's current regulatory environment includes Decree No. 102/2025/NĐ-CP on health data management, effective from 1 July 2025, as well as the Law on Personal Data Protection No. 91/2025/QH15 and Decree No. 356/2025/NĐ-CP, both effective from 1 January 2026.[8–10] Since 19 August 2026, Decree No. 330/2026/NĐ-CP has also provided the administrative-sanctions framework for violations in cybersecurity and personal-data protection.[11]

Measurement should therefore begin with a defined purpose. Healthcare organizations should understand why particular information is required, who needs access, how it relates to the clinical record, where it is stored, how long it is retained, how it is protected and whether third-party platforms or digital tools are involved.

A larger dataset is not automatically a better dataset. The most useful information is information that can be collected reliably, interpreted correctly and used to improve patient care.

Measurement should fit within Vietnamese clinical governance

Where a Lifestyle Medicine program involves medical examination and treatment activities, those activities remain subject to Viet Nam's Law on Medical Examination and Treatment and its applicable implementing regulations. Consolidated Document No. 26/VBHN-VPQH, issued on 26 February 2026, provides the current consolidated text of the Law, while Decree No. 96/2023/NĐ-CP remains an applicable implementing decree.[12,13]

Ministry of Health Circular No. 32/2023/TT-BYT also remains part of the applicable regulatory framework and has been amended by subsequent instruments, including Circular No. 25/2025/TT-BYT and Circular No. 25/2026/TT-BYT. Circular No. 25/2026/TT-BYT was issued on 30 June 2026 and took effect on 15 August 2026.[14]

Measurement does not expand professional authority. The use of a health coach, educator, digital tool or monitoring platform does not independently create authority to diagnose disease, prescribe treatment or perform other regulated clinical activities. Likewise, publication of a proposed VLMA measurement framework does not make the framework a legal requirement, accreditation standard or nationally approved indicator set.

Measurement should therefore sit inside clinical governance, with clear professional responsibility and appropriate escalation when findings require clinical action.

What should healthcare organizations avoid?

One common mistake is measuring what is easy rather than what matters. Attendance, downloads, consultations and educational sessions may be useful process information, but they do not demonstrate that health improved. At the other extreme, collecting too many variables can burden patients and staff while producing incomplete or poor-quality data. Relying on one outcome can be equally misleading: body weight alone cannot describe obesity care, hemoglobin A1c alone cannot describe the full quality of diabetes care, and patient satisfaction alone cannot establish clinical effectiveness.

Organizations should also avoid setting performance targets before understanding their baseline. A benchmark taken from another health system may be clinically inappropriate or operationally unrealistic for the population being served. Targets need context, and unsuccessful referrals, missed follow-up, safety signals, attrition, additional staff workload and patients who do not improve should be treated as useful information rather than excluded because they make the program look less successful.

Measurement should also not become a way of blaming patients. A person who does not meet a lifestyle goal may be dealing with financial constraints, work demands, disability, limited food access, environmental barriers, family responsibilities or other circumstances that the healthcare system needs to understand. Good measurement should help teams understand those circumstances more clearly, not turn a complex clinical situation into a judgment about motivation.

A practical starting point for Vietnamese healthcare organizations

The simplest starting point is to connect measurement directly to the clinical pathway. Define the patient population and the problem the organization is trying to improve. Select one or two core clinical outcome measures that represent meaningful benefit, add the behavioral measure most closely connected to the intervention, identify the critical steps in the pathway and measure whether those steps actually happen. Then add an appropriate safety or balancing measure and consider how the program will understand patient experience, equity and feasibility.

Establish a baseline before making major changes. Once implementation begins, review the data regularly with the clinical team, look at trends rather than isolated numbers and ask patients and staff what the data do not explain. Use those findings to test small changes and measure again.

Over time, indicators that do not help decision-making can be removed and better ones added. The objective is not to build the largest possible dashboard. It is to build a measurement system that becomes more useful as the program learns.

From delivering Lifestyle Medicine to demonstrating meaningful benefit

The future credibility of Lifestyle Medicine in healthcare will not depend only on whether clinicians understand its principles or whether patients find its message appealing. Healthcare organizations will increasingly need to demonstrate that care is clinically meaningful, safe, equitable, measurable and sustainable.

For Viet Nam, this is particularly important because Lifestyle Medicine is developing at the same time that the country is strengthening prevention, grassroots healthcare and community management of noncommunicable diseases.[2,3] This creates an opportunity to build measurement into the field early rather than trying to add it after models of care have already become established.

The objective should not be to create the largest possible set of Lifestyle Medicine indicators, nor should Viet Nam simply import a measurement framework designed for another healthcare system. The more useful task is to identify a small set of measures that answer the questions that matter most: Are we delivering the intended care? Are patients benefiting? Is care safe and equitable? And can the model work reliably in the real Vietnamese healthcare system?

Ultimately, a credible Lifestyle Medicine program should be able to show not only what it delivered, but whether patients benefited, whether care remained safe and equitable, and whether the model can be sustained in the healthcare system.

References and further reading

1. Rea BL, Cheema S, Lanza S, Makinde MT, Matthews S, Palma M, Szentgyörgyi B, Karlsen MC. Lifestyle Medicine Core Competencies: 2025 Update. American Journal of Lifestyle Medicine. 2026;20(3):443–451. doi:10.1177/15598276251379821.

2. World Health Organization Viet Nam. Strengthened grassroots health care brings NCD services to 10 million in Viet Nam. 8 September 2026.

3. National Assembly of Viet Nam. Law on Disease Prevention No. 114/2025/QH15. Adopted 10 December 2025; effective 1 July 2026.

4. Institute for Healthcare Improvement. Model for Improvement: Establishing Measures. Current resource. Reviewed September 2026.

5. World Health Organization. WHO clinical treatment guideline for tobacco cessation in adults. 2 July 2024.

6. World Health Organization. WHOQOL: Measuring Quality of Life and WHOQOL-BREF translation resources. Current resources. Reviewed September 2026.

7. Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, Griffey R, Hensley M. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Administration and Policy in Mental Health. 2011;38(2):65–76. doi:10.1007/s10488-010-0319-7.

8. Government of Viet Nam. Decree No. 102/2025/NĐ-CP on health data management. Effective 1 July 2025.

9. National Assembly of Viet Nam. Law on Personal Data Protection No. 91/2025/QH15. Effective 1 January 2026.

10. Government of Viet Nam. Decree No. 356/2025/NĐ-CP detailing certain provisions and implementation measures of the Law on Personal Data Protection. Effective 1 January 2026.

11. Government of Viet Nam. Decree No. 330/2026/NĐ-CP on administrative penalties for violations in cybersecurity and personal-data protection. Effective 19 August 2026.

12. Office of the National Assembly of Viet Nam. Consolidated Document No. 26/VBHN-VPQH: Law on Medical Examination and Treatment. 26 February 2026.

13. Government of Viet Nam. Decree No. 96/2023/NĐ-CP detailing certain provisions of the Law on Medical Examination and Treatment. Effective 1 January 2024.

14. Ministry of Health of Viet Nam. Circular No. 32/2023/TT-BYT detailing certain provisions of the Law on Medical Examination and Treatment, as amended, including by Circular No. 25/2025/TT-BYT and Circular No. 25/2026/TT-BYT.

Implementation and measurement note: This framework and the example indicators in this article are proposed for professional education, quality improvement and organizational planning. They are not Vietnamese national quality indicators, clinical practice guidelines, accreditation standards or regulatory requirements. Healthcare organizations should define indicators according to the population and clinical pathway being managed, applicable evidence-based guidance, professional scopes of practice, organizational governance, ethical requirements where applicable, and current Vietnamese health-data and personal-data regulations.

Privacy Policy and Personal Data Protection Notice

Terms and Conditions

VLMA is operated by Vietnam Lifestyle Medicine Alliance Company Limited, Enterprise Registration Number 0318902666.

VLMA is a Sister Organization of the Lifestyle Medicine Global Alliance and a Member Organization of the Planetary Health Alliance.

VLMA is not a medical service provider and does not issue medical licenses or IBLM certification.